Search | Engineering

订阅投稿

首页工程期刊工程焦点工程成就工程前沿关于我们 English

资源类型

期刊论文 2

会议视频 2

年份

2023 2

2021 1

2008 1

关键词

前沿技术与中医药创新发展 1

整合药学，整合药物，新药研发，药物评价，临床用药指导 1

营养健康 1

检索范围：

排序：展示方式：

Analysis of the treatment outcomes of esophageal variceal bleeding patients from multiple centers in China

WANG Zhiqiang

《医学前沿（英文）》 2008年第2卷第2期页码 171-173 doi: 10.1007/s11684-008-0031-0

摘要： This study aimed to investigate the treatment outcomes of esophageal variceal bleeding (EVB) in China. A total of 1087 cases were collected from 19 hospitals in 16 large and medium sized cities across China between January 1st, 2005 and January 1st, 2006. There were 313 cases (29.0%) of mild (<400 mL), 494 cases (45.8%) of moderate (400–1500 mL) and 272 cases (25.2%) of severe (>1500 mL) bleeding. Successful hemostasis was achieved in 89.8% of cases. Seven hundred and eighty-five cases were treated by medication with a hemostasis rate of 91.8%. Seventy-one cases were treated using a Sengstaken-Blakemore tube with a hemostasis rate of 54.9%. Thirty-seven cases were treated with emergency endoscopic variceal ligation with a hemostasis rate of 83.8%. Seventy-seven cases were treated with endoscopic sclerotherapy with a hemostasis rate of 94.8%. Forty-three cases were treated with emergency surgical operation with a hemostasis rate of 95.3%. Sixty-six cases were treated with combined therapy with a hemostasis rate of 97.0%. There was a significant difference ( < 0.01) in the successful hemostasis rate between different treatments. The overall mortality was 10.1%, among which 6.6% was directly caused by bleeding. The multivariate logistic regression analysis shows that the severity of bleeding, treatment methods, liver dysfunction and activation of hepatitis were predictive factors for successful hemostasis. Most cases of EVB were mild and moderate in severity. The first-line treatment for EVB is medication. Emergency endoscopic intervention has not been widely available yet. The overall management outcome of EVB has been improved.

关键词： significant difference predictive medication first-line treatment bleeding

HTML PDF 收藏

整合药学发展的战略思考

张勇,赵一秀,杨宝峰

《中国工程科学》 2021年第23卷第1期页码 185-192 doi: 10.15302/J-SSCAE-2021.01.022

摘要：

整合药学是以现代药学为基础、随着人类对复杂性疾病认识的日益深刻而提出来的，涉及新药研发、传统医药创新、临床药学实践、药学学科建设及人才培养等诸多领域。为推进我国整合药学实践的发展，本文运用文献研究、学术交流、专家咨询等方法，阐明了整合药学理念及内涵，提出了整合药学的未来发展战略。研究指出，要促进现代药学与传统药学的整合，应建立健全整合用药临床实践指南、鼓励基于整合思维的创新中药研究、规范整合中西药临床应用；推进基于整合药学的新药研发，应创新整合药物设计思路、开发适应整合药学的药物评价体系、加快建设整合药物的新药研发体系；推进整合药学的临床实践，应进一步完善以患者为中心的临床用药指导、实现个体化治疗、丰富整合药学临床实践内容、加强整合药物合理应用；推进整合药学学科建设，应丰富基于整合药学的药学本科理论和实践课程、加强教育培训及专业间协作。整合药学是现代药学理论和实践的变革与发展，融合药学各相关学科的理论与实践，是构建促进人类健康、完善医疗体系的新型药学理论和实践体系。

关键词：整合药学，整合药物，新药研发，药物评价，临床用药指导

HTML PDF 收藏